Talking about immunity can be a complex beast at the best of times, right now it’s almost impossible. Let’s try to clear up some of the mess and confusion over…
These are challenging times, perhaps the most defining in all of our lifetimes.Weeks from now, there will be a whole new normal, laying on top of the scar tissue being…
Last week was disappointing. Some have used stronger, more dramatic words, but I think many of us walked around in a bit of a fog. Some were on their way…
The role the microbiome plays in disease and health is becoming more understood with each passing week and new study. That fact was truly a foundation at the recently concluded…
This edition of “What’s Wrong with This Picture?” highlights a pharmaceutical development company that develops and commercializes anti-inflammatory dietary supplements and drugs. The only revenue source, outside of investment funding,…
As I sat down to write this piece, it ultimately became part reflection, part snapshot. This next decade is going to be interesting for our supplement marketplace.There were numerous conversations…
As we kick off a new year and new decade, I figured I’d write a few words outlining our ITC thoughts, to augment the What’s Hot / What’s Not info…
This is year three for ITC’s trend predictions and for the most part they’ve held up (check last year’s here). Developing these is never easy—our team has multiple conversations/debates etc.…
I returned Food Ingredients Europe in Paris last week with a solid reaffirmation – try to avoid industry events in France. Don’t get me wrong, this is not an indictment…
Our weekly posts have been entertaining and thought provoking to write. We have covered a number of topics ranging from hopeful to insightful. Today’s post originated with a series of…
Industry Transparency Center is not a chartered bank, trust company, or depository institution and is not authorized to accept deposits or trust accounts and is not licensed or regulated by any state or federal banking authority. Read our privacy policy.
